Nocturnal blood pressure and progression to end-stage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4

Redón, Josep; Plancha, Eva; Swift, Pauline A.; Pons, S; Muñóz, J. Cuesta; Martínez, Fernando

doi:10.1097/hjh.0b013e328333fe4d

Cited by 54 publications

(40 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a recent study, Redon et al 25 have shown that the prevalence of non-dippers in patients with stages 3 or 4 chronic kidney disease was 47%, far below our 72.1% observation. Possible explanations include an office BP considerably lower in the former study and differences in the methodology for diagnosing the dipping status with regard to the nighttime period definition.…”

Section: Circadian Bp Variation and Risk Categoriescontrasting

confidence: 81%

“…Possible explanations include an office BP considerably lower in the former study and differences in the methodology for diagnosing the dipping status with regard to the nighttime period definition. 21,25 In summary, high-risk hypertensives show a remarkable high prevalence of abnormalities in circadian BP variation with a key influence in absolute levels of nighttime and 24-h BP. These observations support the recommendation of a wider use of ABPM in high-risk hypertensive patients.…”

Section: Circadian Bp Variation and Risk Categoriesmentioning

confidence: 99%

See 1 more Smart Citation

Diurnal blood pressure variation, risk categories and antihypertensive treatment

et al. 2010

View full text Add to dashboard Cite

Ambulatory blood pressure (BP) monitoring is a useful tool aiding diagnostic and management decisions in patients with hypertension. Diurnal BP variation or circadian rhythm adds prognostic value to the absolute BP elevation. The Spanish ABPM Registry has collected information from 430 000 treated hypertensive patients attended by either primary care physicians or referral specialists. The analysis of BP diurnal variation has allowed the conclusion that nocturnal BP decline is related to the level of risk. Patients with blunted nocturnal dip frequently belong to high-or very high-risk categories and specifically are often older, obese, diabetics or with overt cardiovascular or renal disease. With respect to treatment, the non-dipper profile is more often observed in patients receiving several antihypertensive drug agents, but it does not correlate with the time of drug administration. Among patients receiving only one drug, non-dihydropyridine calcium channel blockers and a-blockers are associated with less nocturnal BP decline than other antihypertensive drug classes, even after adjusting for the level of risk.

show abstract

Section: Circadian Bp Variation and Risk Categoriescontrasting

confidence: 81%

Section: Circadian Bp Variation and Risk Categoriesmentioning

confidence: 99%

Diurnal blood pressure variation, risk categories and antihypertensive treatment

et al. 2010

View full text Add to dashboard Cite

show abstract

“…In CKD patients, non-dipping was found to be associated with poor renal outcomes, 13,14 but other studies report no relationship. 15, 17 Additionally, in people with preserved kidney function, one study reported a significant association of non-dipping with deterioration of kidney function, 28 but another study did not. 16 High nocturnal BP is, in some cases, accompanied by a non-dipping pattern, but both patterns are not always present together and there are differences in the significance between nocturnal BP and the non-dipping pattern.…”

Section: Discussionmentioning

confidence: 99%

“…Redon et al reported a greater risk for progression to ESRD in patients with night-time SBP higher than 130 mmHg in nondiabetic patients at CKD stages 3 and 4. 17 Another study reported that night-time SBP levels enabled more accurate prediction of renal and cardiovascular risk than daytime SBP levels in patients with CKD stages 2-5. 14 Nevertheless, whether night-time SBP is superior to daytime SBP has not been fully investigated in the general CKD patient population.…”

Section: Measurement Of Abpmmentioning

confidence: 99%

See 1 more Smart Citation

Comparison of Prognostic Values of Daytime and Night-Time Systolic Blood Pressures on Renal Outcomes in Patients With Chronic Kidney Disease

Katafuchi

Nakayama

Tanaka

et al. 2017

Circ J

View full text Add to dashboard Cite

Background: Differences in the predictive value of daytime systolic blood pressure (SBP) and night-time SBP by ambulatory blood pressure monitoring on renal outcomes have not been fully investigated in chronic kidney disease (CKD) patients. This study compared the prognostic value between daytime and night-time SBP on renal outcomes in CKD. Methods and Results:This prospective observational study included 421 patients. The composite renal endpoint was endstage renal disease (ESRD) or death. Cox models were used to determine associations of daytime and night-time SBP with renal outcomes. There were 150 renal events (ESRD, 130; death,20). Multivariable Cox analyses demonstrated that hazard ratios (HRs) [95% confidence interval (CI)] for composite renal outcomes of every 10-mmHg increase in daytime and night-time SBP levels were 1.13 (1.02-1.26) (P=0.02) and 1.15 (1.05-1.27) (P<0.01), respectively. In addition, compared with the 1st daytime or night-time SBP quartile, HRs (95% CI) for outcomes in the 2nd, 3rd, and 4th quartiles were: daytime SBP, 1.25 (0.70-2.25), 1.09 (0.61-1.94), and 1.58 (0.88-2.85; P=0.13) (P for trend=0.16); night-time SBP, 1.09 (0.61-1.96), 1.31 (0.76-2.28), and 1.82 (1.00-3.30; P=0.049) (P for trend=0.03), respectively. Conclusions:Night-time SBP appeared superior to daytime SBP for predicting renal outcomes in this population of patients.

show abstract

Prognostic Role of Ambulatory Blood Pressure Measurement in Patients With Nondialysis Chronic Kidney Disease

Minutolo¹,

Agarwal²,

Borrelli³

et al. 2011

Arch Intern Med

272

185

View full text Add to dashboard Cite

show abstract

Nocturnal blood pressure and progression to end-stage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4

Abstract: Glomerular filtration rate and nocturnal SBP values, but not nondipper pattern, were associated with risk to develop ESRD.

Cited by 54 publications

References 22 publications

Diurnal blood pressure variation, risk categories and antihypertensive treatment

Diurnal blood pressure variation, risk categories and antihypertensive treatment

Comparison of Prognostic Values of Daytime and Night-Time Systolic Blood Pressures on Renal Outcomes in Patients With Chronic Kidney Disease

Prognostic Role of Ambulatory Blood Pressure Measurement in Patients With Nondialysis Chronic Kidney Disease

Contact Info

Product

Resources

About